{
  "abstract": "Coronavirus disease 2019 (COVID-19) has been associated with an increased thrombotic risk, potentially exacerbated in patients with active cancer. We conducted a retrospective cohort study including 119 cancer patients with COVID-19 and 214 matched prepandemic controls. Patients with COVID-19 had poorer performance status and were more frequently treated with palliative intent. After a median follow-up of 32.7 months, overall thrombotic event rates did not differ between groups. However, after adjustment for clinically relevant covariates and accounting for death as a competing event, COVID-19 status and palliative treatment intent remained independently associated with a higher cumulative incidence of thrombotic events. In conclusion, COVID-19 may increase thrombotic risk in patients with cancer and occurs more frequently in patients with poorer clinical status. These findings are exploratory and require confirmation in larger prospective studies.",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": "brief report",
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "name": "Jérôme Doyen",
      "orcid": "0000-0003-4646-4778"
    },
    {
      "name": "Alexandre Lacour"
    },
    {
      "name": "Renaud Schiappa"
    },
    {
      "name": "Eva Seutin"
    },
    {
      "name": "Amanda Garrido"
    },
    {
      "name": "Tanguy Pace Loscos"
    },
    {
      "name": "Denis Doyen"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/88y31v3tgea1f.bib",
  "cited_by": 0,
  "doi": "10.1093/jncics/pkag110",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13713195/",
  "id": "88y31v3tgea1f",
  "issns": [
    "2515-5091"
  ],
  "landing_url": "https://doi.org/10.1093/jncics/pkag110",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "AcademicSubjects/MED00010"
    ],
    [
      "heading",
      "Brief Communications"
    ],
    [
      "openalex",
      "2724|Venous Thromboembolism Diagnosis and Management"
    ]
  ],
  "openalex": "W7221548136",
  "pdf_url": null,
  "pmcid": "PMC13713195",
  "pmid": "42862724",
  "published": "2026-10-12",
  "publisher": "Oxford University Press",
  "ris": "https://research.draconitic.com/paper/88y31v3tgea1f.ris",
  "sources": [
    {
      "first_seen": "2026-10-31T12:23:35Z",
      "native_id": "PMC13713195",
      "source": "pmc",
      "url": "https://doi.org/10.1093/jncics/pkag110"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "journal-openalex:2730|Global Cancer Incidence and Screening",
      "subfield": "oncology"
    }
  ],
  "title": "COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study",
  "title_text": "COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study",
  "type": "peer-reviewed",
  "updated_at": "2026-10-31T12:23:35Z",
  "url": "https://research.draconitic.com/paper/88y31v3tgea1f",
  "venue": "JNCI Cancer Spectrum",
  "versions": []
}